Testing effectiveness (Phase 2)Study completedNCT03936270
What this trial is testing
Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer
Who this might be right for
Ovarian Cancer
Latin American Cooperative Oncology Group 43